Earnings Summary

Moderna, Inc.’s revenue jumped 1.69% since last year same period to $1862Mn in the Q3 2024. On a quarterly growth basis, Moderna, Inc. has generated 672.61% jump in its revenue since last 3-months.

Moderna, Inc.’s net profit jumped 100.36% since last year same period to $13Mn in the Q3 2024. On a quarterly growth basis, Moderna, Inc. has generated 101.02% jump in its net profits since last 3-months.

Moderna, Inc.’s net profit margin jumped 100.35% since last year same period to 0.7% in the Q3 2024. On a quarterly growth basis, Moderna, Inc. has generated 100.13% jump in its net profit margins since last 3-months.

Moderna, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.9 - a 43.79% jump from last quarter’s estimates.

Moderna, Inc.’s earning per share (EPS) estimates for the current year stand at -1.9.

Moderna, Inc.’s earning per share (EPS) jumped 100.31% since last year same period to 0.03 in the Q3 2024. This indicates that the Moderna, Inc. has generated 100.31% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Moderna, Inc.’s return on assets (ROA) stands at -0.1.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Moderna, Inc.’s return on equity (ROE) stands at -0.18.